Medical Communications

New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …

The cost of treatment for multiple sclerosis varies wildly, in the UK treatment can cost £56,000 per year while in …

It’s Friday again, and the past week was populated with a host of riveting news and features from the life …

It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …

A study has found that the rates of children dying from diarrhoea worldwide fell by a third through the decade …

Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …

Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …

Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …

The stakes are high as the UK general election draws ever closer, and the industry has come out in force …

A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for …

If there is one state that needs answers for its citizens’ struggles with opioids, it is Ohio. The state saw …

In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …

Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …

Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …

Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …